Letter: Presence of progression or absence of response? Alternative trial designs for immunotherapy of advanced hepatocellular carcinoma. Authors' reply

  • 0Department of Hepatology and Gastroenterology, Charité - Universitätsmedizin Berlin, Berlin, Germany.

|

|

Summary

No abstract available on PubMed